Restoration of immunocompetence in aging and other inflammatory disease states by dehydroepiandrosterone- 3β-sulfate, an activator of the peroxisome proliferator-activated receptor alpha (PPARα)

Dehydroepiandrosterone (DHEA): Biochemical, Physiological and Clinical Aspects

Volumn , Issue , 2011, Pages 65-118

  Poynter, Matthew E ^a,b   Daynes, Raymond A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85064941368     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (415)

1. van der Bosch, H., Schutgens, R.B.H., Wanders, R.J.A., and Tager, J.M. 1992. Biochemistry of peroxisomes. Annu. Rev. Biochem. 61:157-197
2. Moser, H.W. 1993. Peroxisomal diseases. In Advances in Human Genetics. H. Harris, and K. Hirschhorn, editors. New York:Plenum Press. 1-106
3. Naidu, S., and Moser, H.W. 1994. Peroxisomal disorders. Pediatric Neurogenetics. 12:727-739
4. Reddy, J.K., and Mannaerts, G.P 1994. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 14:343-370
5. Issemann, I., and Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:645-650
6. Lemberger, T., Desvergne, B., and Wahli, W. 1996. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Ann. Rev. Cell. Dev. Biol. 12:335-363
7. Yamamoto, K.R. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19:209-252
8. Miesfeld, R.L., Rusconi, S., Godowski, P.J., Maler, B.A., Okret, S., Wikstrom, A.-C., Gustafsson, A., and Yamamoto, K.R. 1986. Genetic complementation of a glucocorticoid receptor deficiency by expression of a cloned receptor cDNA. Cell. 46:389-399
9. Hollenberg, S.M., Weinberger, C., Ong, E.S., Cerelli, G., Oro, A.E., Lebo, R., Thompson, E.B., Rosenfeld, M.B., and Evans, R.M. 1985. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:635-641
10. Green, S., Walter, V., Kumar, V., Krust, A., Bornet, J.-M., Argos, P., and Chambon, P. 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 320:134-139
11. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., and Chambon, P. 1990. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603-1614
12. Kemppainen, J.A., Lane, M.V., Sar, M., and Wilson, E.M. 1992. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267:968-974
13. Sap, J., Munoz, A., Damm, K., Goldberg, Y., Ghysdael, J., Leutz, A., Beug, H., and Vennstrom, B. 1986. The c-erb-A protein is a high affinity receptor for thyroid hormone. Nature. 324:635-640
14. Petkovich, M., Brand, N.J., Krust, A., and Chambon, P. 1987. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:444-450
15. Laudet, V., Hanni, C., Coll, J., Catzeflis, F., and Stehelin, D. 1992. Evolution of the nuclear receptor gene superfamily. EMBO J. 11:1003-1013
16. Desvergne, B., and Wahli, W. 1995. PPAR: a key nuclear factor in nutrient/gene interactions? In Inducible Transcriptions. P. Baeuerle, editor. Boston:Birkhauser. 142-176
17. Gearing, K.L., Göttlicher, M., Teboul, M., Widmark, E., and Gustafsson, J.-ä. 1993. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sei. USA. 90:1440-1444
18. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., and Wahli, W. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor retinoid X receptor heterodimers. Proc. Natl. Acad. Sei. USA. 90:2160-2164
19. Lawrence, J.W., Foxworthy, P.S., Perry, D.N., Jensen, C.B., Giera, D.D., Meador, V.P., and Eacho, P.I. 1995. Nefenopin-induced peroxisome proliferation in vitamin A deficient rats. Biochem. Pharmacol. 49:915-919
20. Solhenius, A.K., Reinfeldt, M., Backstrom, K., Bergstrand, A., and DePierre, J.W. 1996. Hepatic peroxisome proliferation in vitamin A-deficient mice without a simultaneous increase in peroxisomal acyl-CoA oxidase activity. Biochem. Pharmacol. 51:821-827
21. Solhenius, A.K., Andersson, K., Olsson, J., and DePierre, J.W. 1995. Peroxisome proliferation and associated effects caused by petrofluorooctanoic acid in vitamin A-deficient mice. Chem. Biol. Interact. 98:45-50
22. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A., and Evans, R.M. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimerization of their receptors. Nature. 358:771-774
23. Isseman, I., Prince, R.A., Tugwood, J.D., and Green, S. 1993. The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie (Paris). 75:251-256
24. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A.G., Wahli, W., Meier, C.A., and Desvergne, B. 1997. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. J. Biol. Chem. 272:25252-25259
25. Glass, C.K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391-407
26. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundeil, K.R., McPheat, W.L., and Green, S. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl-CoA oxidase gene. EMBO J
27. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. 1992. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68:879-887
28. Palmer, C.N., Hsu, M.H., Griffin, H.J., and Johnson, E.F. 1995. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270:16114-16121
29. Dowell, P., Peterson, V.J., Zabriskie, T.M., and Leid, M. 1997. Ligand-induced peroxisome proliferator-activated receptor alpha conformational change. J. Biol. Chem. 272:2013-2020
30. Dowell, I., J.E., Avram, D., Peterson, V.J., Nevrivy, D.J., and Leid, M. 1997. p300 functions as a coactivator for the peroxisome proliferator-activated receptor a. J. Biol. Chem. 272:33435-33443
31. Ogryzko, V.V., Schlitz, R.L., Russanova, V., Howard, B.H., and Nakatani, Y. 1996. The transcriptional coactivators p300 and CBPare histone acetyltransferases. Cell. 87:953-959
32. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein El A. Nature. 382:319-342
33. Bannister, A.J., and Kouzarides, T. 1996. The CBP co-activator is a histone acetyltransferase. Nature. 384:641-643
34. Zhu, Y., Qi, C., Calandra, C., Rao, M.S., and Reddy, J.K. 1996. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. Gene Exp. 6:185-195
35. DiRenzo, J., Soderstrom, M., Kurokawa, R., Ogliastro, M.H., Ricote, M., Ingrey, S., Horlein, A., Rosenfeld, M.G., and Glass, C.K. 1997. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol. Cell. Biol. 17:2166-2176
36. Janknecht, R., and Hunter, T. 1996. A growing coactivator network. Nature. 383:22-23
37. Chen, F., Law, S.W., and O'Malley, B.W. 1993. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem. Biophys. Res. Comm. 196:671-677
38. Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D., and Rodan, G.A. 1992. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol. Endocrin. 6:1634-1641
39. Sher, T., Yi, H.F., McBride, O.W., and Gonzalez, F.J. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator-activated receptor. Biochem. 32:5598-5604
40. Greene, M.E., Blumberg, B., McBride, O.W., Yi, H.F., Kronquist, K., Kwan, K., Hsieh, L., Greene, G., and Nimer, S.D. 1995. Isolation of the human peroxisome proliferator-activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Exp. 4:281-299
41. Zhu, Y., Alvares, K., Huang, Q., Rao, M.S., and Reddy, J.K. 1993. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268:26817-26820
42. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K., and Evans, R.M. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sei. USA. 91:7355-7359
43. Amri, E.Z., Bonino, F., Ailhaud, G., Abumrad, N.A., and Grimaldi, P.A. 1995. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J. Biol. Chem. 270:2367-2371
44. Xing, G.Q., Zhang, L.X., Zhang, L., Heynen, T., Yoshikawa, T., Smith, M., Weiss, S., and Detera-Wadleigh, S. 1995. Rat PPAR-delta contains a CGG triplet repeat and is predominantly expressed in the thalamic nuclei. Biochem. Biophys. Res. Comm. 217:1015-1025
45. Göttlicher, M., Widmark, E., Li, Q., and Gustafsson, J.-A. 1992. Fatty acids activate a chimera of the Clofibrate acid-activated receptor and the glucocorticoid receptor. Biochem. 89:4653-4657
46. Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J., and Boulukos, K.E. 1995. cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPARgamma. Gene. 162:297-302
47. Sundvold, H., Brzozowska, A., and Lien, S. 1997. Characterisation of bovine peroxisome proliferator-activated receptors γ and γ2: genetic mapping and differential expression of the two isoforms. Biochem. Biophys. Res. Comm. 239:857-861
48. Ruyter, B., Andersen, O., Dehli, A., Farrants, A.-K.O., Gjoen, T., and Thomassen, M.S. 1997. Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. Biochim. Biophys. Acta. 1348:331-338
49. Kockx, M., Princen, H.M., and Kooistra, T. 1996. Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey. Ann. N.Y.Acad. Sei. 804:711-712
50. Guan, Y., Zhang, Y., Davis, L., and Breyer, M.D. 1997. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am. J. Physiol. 273:F1013-1022
51. Miyata, K.S., Zhang, B., Marcus, S.L., Capone, J.P., and Rachubinski, R.A. 1993. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome-proliferator-mediated signaling. J. Biol. Chem. 268:19169-19172
52. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α,-β, and-γ in the adult rat. Endocrinol. 137:354-366
53. Poynter, M.E., and Daynes, R.A. accepted. PPARa activation modulates cellular redox status, represses NFkB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem
54. Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J.P., Staels, B., Auwerx, J., Laville, M., and Vidal, H. 1997. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-a in humans. Diabetes. 46:1319-1327
55. Palmer, C.N.A., Hsu, M.-H., Griffin, K.J., Raucy, J.L., and Johnson, E.F. 1998. Peroxisome proliferator-activated receptor-a expression in human liver. Mol. Pharmacol. 53:14-22
56. Lock, E.A., Mitchell, A.M., and Elcombe, C.R. 1989. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29:145-163
57. Elcombe, C.R., and Mitchell, A.M. 1986. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. Environ. Health Perspect. 70:211-219
58. Blaauboer, B.J., Van Holsteijn, C.W.M., Bleumink, R., Mennes, W.C., Van Pelt, F.N.A.M., Yap, S.H., Van Pelt, J.F., Van Iersel, A.A.J., Timmerman, A., and Schmid, B.P. 1990. The effect of beclofibric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem. Pharmacol. 40:521-528
59. Bichet, N., Cahard, D., Fabre, G., Remandet, B., Gouy, D., and Cano, J.-P. 1990. Toxicological studies on a benzofuran derivative. III. Comparison of peroxisome proliferation in rat and human hepatocytes in primary culture. Toxicol. Appl. Pharmacol. 106:509-517
60. Lake, B.G., Evans, J.G., Gray, T.J., Korosi, S.A., and North, C.J. 1989. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. Toxicol. Appl. Pharmacol. 99:148-160
61. Bell, D.R., Plant, N.J., Rider, C.G., Na, L., Brown, S., Ateitalla, I., Acharya, S.K., Davies, M.H., Elias, E., and Jenkins, N.A. 1993. Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs. Biochem. J. 294:173-180
62. Pacot, C., Petit, M., Rollin, M., Behechti, N., Moisant, M., Deslex, P., Althoff, J., Lhuguenot, J.C., and Latruffe, N. 1996. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate. Arch. Biochem. Biophys. 327:181-188
63. Bell, A.R., Savory, R., Horley, N.J., Choudhury, A.I., Dickins, M., Gray, T.J.B., Salter, A.M., and Bell, D.R. 1998. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARa is functional and mediates peroxisome proliferator-induced hypolipidaemia. Biochem. J. 332:689-693
64. Forman, B.M. 1997. Orphan nuclear receptors and their ligands. In Biology of Steroid and Nuclear Hormone Receptors. L. P. Freedman, editor. Boston:Birkhauser. 281-305
65. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARy). J. Biol. Chem. 270:12953-12956
66. Desvergne, B., Ijpenberg, A., Devchand, P.R., and Wahli, W. 1998. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signaling. J. Steroid Biochem. Mol. Biol. 65:65-74
67. Kliewer, S.A., Lenhard, J.M., Wilson, T.W., Patel, I., Morris, D.C., and Lehmann, J.A. 1995. A prostaglandin J2 metabolite binds peroxisome peroliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:813-819
68. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M. 1995. 15-Deoxy-A1214-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARy. Cell. 83:803-812
69. Ren, B., Thelen, A., and Jump, D.B. 1996. Peroxisome proliferator-activated receptor a inhibits hepatic S14 gene transcription: Evidence against the peroxisome proliferator-activated receptor a as the mediator of polyunsaturated fatty acid regulation ofS14 gene transcription. J. Biol. Chem. 271:17167-17173
70. Schoonjans, K., Staels, B., and Auwerx, J. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925
71. Gearing, K.L., Gottlicher, M., Widmark, E., Banner, C.D., Toilet, P., Stromstedt, M., Rafter, J.J., Berge, R.K., and Gustafsson, J.-A. 1994. Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene family. J. Nutr. 124:1284S-1288S
72. Devchand, P.R., Keller, H., Peters, J.M., Vazquez, M., Gonzalez, F.J., and Wahli, W. 1996. The PPARa-leukotriene B4 pathway to inflammation control. Nature. 384:39-43
73. Yu, K., Bayona, W., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon, G., Brown, M., and Lazar, M.A. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-23983
74. Calder, P.C. 1998. Fat chance of immunomodulation. Immunol. Today. 19:277-247
75. Osmundsen, H., Braud, H., Beauseigneur, F., Gresti, J., Tsoko, M., and Clouet, P. 1998. Effect of dietary treatment of rats with eicosapentaenoic acid or docosahexaenoic acid on hepatic lipid metabolism. Biochem. 7.331:153-160
76. Kawashima, Y., and Kozuka, H. 1993. Dietary manipulation by perilla oil and fish oil of hepatic lipids and its influence on peroxisomal β-oxidation and serum lipids in rat and mouse. Biol. Pharm. Bull. 16:1194-1199
77. Fiatmark, T., Nilsson, A., Kvannes, J., Eikhom, T.S., Fukami, M.H., Kryvi, H., and Christiansen, E.N. 1988. On the mechanism of induction of the enzyme systems for peroxisomal β-oxidation of fatty acids by diets rich in partially hydrogenated fish oil. Biochim. Biophys. Acta. 962:122-130
78. De Craemer, D., Vamecq, J., Roels, F., Vallee, L., Pauwels, M., and Van den Branden, C. 1994. Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: original data and review on peroxisomal changes induced by high-fat diets. 7. Lipid Res. 35:1241-1250
79. Berge, R.K., Fiatmark, T., and Christiansen, E.N. 1987. Effect of a high-fat diet with partially hydrogenated fish oil on long chain fatty acid metabolizing enzymes in subcellular fractions of rat liver. Arch. Biochem. Biophys. 252:269-276
80. Kryvi, H., Christiansen, E., Tangeras, A., and Fiatmark, T. 1986. Effects of essential fatty acid deficiency on mitochondria and peroxisomes in rat hepatocytes with special reference to a partially hydrogenated fish oil diet. Biochim. Biophys. Acta. 881:87-92
81. Forman, B.M., Chen, J., and Evans, R.M. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sei. USA. 94:4312-4317
82. Schmidt, A., Vogel, R.L., Witherup, K.M., Rutledge, S.J., Pitzenberger, S.M., Adam, M., and Rodan, G.A. 1996. Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family. Lipids. 31:1115-1124
83. Johnson, T.E., Holloway, M.K., Vogel, R., Rutledge, S.J., Perkins, J.J., Rodan, G.A., and Schmidt, A. 1997. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. 7. Steroid Biochem. Mol. Biol. 63:1-8
84. Moody, D.E. 1994. Peroxisome proliferation: An overview. In Peroxisome proliferators: Unique inducers of drug-metabolizing enzymes. D. E. Moody, editor. Boca Raton:CRC Press. 1-26
85. Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M., and Kliewer, S.A. 1997. Peroxisome proliferator-activated receptors a and β are activated by indomethacin and other non-steroidal anti-inflammatory drugs. 7. Biol. Chem. 272:3406-3410
86. Eacho, P.I., Foxworthy, P.S., Dillard, R.P., Whitesitt, C.A., Herron, D., K., and Marshall, W.S. 1989. Induction of peroxisomal beta-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: structure activity relationships. Toxicol. Appl. Pharmacol. 100:177-184
87. Sakuma, M., Yamada, J., and Suga, T. 1993. Induction of peroxisomal β-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships. Biochim. Biophys. Acta. 1169:66-72
88. Lake, B.G. 1995. Peroxisome proliferation: current mechanisms relating to non-genotoxic carcinogenesis. Toxicol. Lett. 82/83:673-681
89. Mannaerts, G.P., and Van Veldhoven, P.P. 1993. Metabolic role of mammalian peroxisomes. In Peroxisomes: biology and importance in toxicology and medicine. G. Gibson, and B. Lake, editors. London:Taylor & Francis Ltd. 19-62
90. Chance, B., Sies, H., and Boveris, A. 1979. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:527-605
91. Demoz, A., Willumsen, N., and Berge, R.K. 1992. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids. 27:968-971
92. Klucis, E., Crane, D., and Masters, C. 1985. Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs. Molec. Cell. Biochem. 65:73-82
93. Tamura, H., Iida, T., Watanabe, T., and Suga, T. 1990. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Carcinogenesis. 11:445-450
94. Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., and Gonzalez, F.J. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor a (PPARa)./. Biol. Chem. 273:5678-5684
95. Bach, M.A. 1977. Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy, and thymic factor. J. Immunol. 119:641-647
96. Brandt, J.M., Djouadi, F., and Kelly, D.P. 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor a. J. Biol. Chem. 273:23786-23792
97. Mascaro, C., Acosta, E., Oritz, J., Marrero, P., Hegardt, F., and Haro, D. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273:8560-8563
98. Haning Jr, R.V., Austin, C.W., Carlson, I.H., Kuzma, D.L., andZweibel, W.J. 1985. Role of dehydroepiandrosterone as a prehormone for ovarian steroidogenesis. Obstet. Gynecol. 65:199-205
99. Haning Jr, R.V., Hackett, R.J., Flood, C.A., Loughlin, J.S., Zhao, Q.Y., and Longcope, C. 1993. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J. Clin. Endocrinol. Metab. 76:1301-1307
100. Regelson, W., Loria, R., and Kalimi, M. 1988. The role of dehydroepiandrosterone (DHEA), thyroid hormone, estrogen and hypophysectomy in aging. Ann. N. Y Acad. Sei. 521:260-273
101. Regelson, W., and Kalimi, M. 1994. Dehydroepiandrosterone (DHEA)-the multifucntional steroid II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann. N.Y.Acad. Sei. 719:564-575
102. Regelson, W., Loria, R., and Kalimi, M. 1994. Dehydroepiandrosterone (DHEA)-the "mother steroid" I. Immunologic action. Ann. N.Y.Acad. Sei. 719:553-562
103. Majewska, M.D., Demirogen, S., Spivak, C.E., and London, E.D. 1990. The neurosteroid DHEAS is an allosteric antagonist of the GAB A receptor. Brain Research. 526:143-146
104. Rao, M.S., Subbarao, V., Kumar, S., Yeldandi, A.V., and Reddy, J.K. 1992. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. J.P.N. J. Cancer Res. 83:1179-1183
105. Rao, M.S., Musunuri, S., and Reddy, J.K. 1992. Dehydroepisterone-induced peroxisome proliferation in the rat liver. Pathobiology. 60:82-86
106. Rao, M.S., Reid, B., Ide, H., Subbaro, I.V., and Reddy, J.K. 1994. Dehydroepiandrosterone-induced peroxisome proliferation in the rat: Evaluation of sex differences. Proc. Soc. Exp. Biol. Med. 207:186-190
107. Rao, M.S., and Reddy, J.K. 1996. Hepatocarcinogenesis of peroxisome proliferators. Ann. N.Y. Acad. Sei. 804: 573-587
108. Yamada, J., Sakuma, M., Ikeda, T., Fukuda, K., and Suga, T. 1991. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta. 1092:233-243
109. Sakuma, M., Yamada, J., and Suga, T. 1992. Comparison of the inducing effect of dehydroepiandrosterone on hepatic peroxisome proliferation-associated enzymes in several rodent species. A short term administration study. Biochem. Pharmacol. 43:1269-1273
110. Hayashi, F., Tamura, H., Yamada, J., Kasai, H., and Suga, T. 1994. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis. 15:2215-2219
111. Frenkel, R.A., Slaughter, C.A., Orth, K., Moomaw, C.R., Hicks, S.H., Snyder, J.M., Bennett, M., Prough, R.A., Putnam, R.S., and Milewich, L. 1990. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J. Steroid Biochem. 35:333-342
112. Prough, R.A., Webb, S.J., Wu, H.-Q., Lapenson, D.P., and Waxman, D.J. 1994. Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolites in rats. Cancer Res. 54: 2878-2886
113. Feller, D.R., Singh, Y., Shirhatti, V.R., Kocarek, T.A., Liu, C.T., and Krishna, G. 1987. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes. Hepatology. 7:508-516
114. Kocarek, T.A., and Feller, D.R. 1987. Induction of peroxisomal fatty acyl-CoA oxidase and microsomal laurate hydroxylase activities by beclobric acid and two metabolites in primary rat hepatocytes. Biochem. Pharmacol. 36:3027-3032
115. Kocarek, T.A., and Feller, D.R. 1989. Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes. Biochem. Pharmacol. 38:4169-4176
116. Gray, T.J.B., Lake, B.G., Beamand, J.A., Foster, J.R., and Gangolli, S.D. 1983. Peroxisome proliferation in primary cultures of rat hepatocytes. Toxicol. Appl. Pharmacol. 67:15-25
117. Bell, D.R., and Elcombe, C.R. 1991. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in primary rat hepatocyte culture by peroxisome proliferators. Biochem. J. 280:249-253
118. Ram, P.A., and Waxman, D.J. 1994. Dehydroepiandrosterone 3β-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca2+-channel blockers. Biochem. J. 301:753-758
119. Yamada, J., Sakuma, M., Ikeda, T., and Suga, T. 1994. Activation of dehydroepiandrosterone as a peroxisome proliferator by sulfate conjugation. Arch. Biochem. Biophys. 313:379-381
120. Yamada, J., Sugiyama, H., Sakuma, M., and Suga, T. 1994. Specific binding of dehydroepiandrosterone sulfate to rat liver cytosol: a possible association with peroxisomal enzyme induction. Biochim. Biophys. Acta. 1224:139-146
121. Dreyer, C., Keller, H., Mahfoudi, A., Laudet, V., Krey, G., and Wahli, W. 1993. Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell. 77:67-76
122. Gottlicher, M., Widmark, E., Li, Q., and Gustafsson, J.A. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sei. USA. 89:4653-4657
123. Boie, Y., Adam, M., Rushmore, T.H., and Kennedy, B.P. 1993. Enantioselective activation of the peroxisome proliferator-activated receptor. J. Biol. Chem. 268:5530-5534
124. Waxman, DJ. 1996. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J. Endocrinol. 150:S 129-S147
125. Lalwani, N.D., Fahl, W.E., and Reddy, J.K. 1983. Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochem. Biophys. Res. Comm. 116:388-393
126. Lee, S.S.-T., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Femandez-Salguero, P.M., Westphal, H., and Gonzalez, F.J. 1995. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:3012-3022
127. Lee, S.S.T., and Gonzalez, F.J. 1996. Targeted disruption of the peroxisome proliferator-activated receptor a gene, PPARa. Ann. N. Y. Acad. Sei. 804:524-529
128. Peters, J.M., Zhou, Y.-C., Ram, P.A., Lee, S.S.T., Gonzalez, F.J., and Waxman, D.J. 1996. Peroxisome proliferator-activated recepter alpha required for gene induction by dehydroepiandrosterone-3β-sulfate. Mol. Pharmacol. 50:67-74
129. Itoga, H., Tamura, H., Watanabe, T., and Suga, T. 1990. Characteristics of the suppressive effects of nicardipine on peroxisome induction in rat liver. Biochim. Biophys. Acta. 1051:21-28
130. Bennett, A.M., and Williams, G.M. 1992. Reduction of rat liver endoplasmic reticulum Ca(2+)-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator. Biochem. Pharmacol. 43:595-605
131. Bennett, A.M., and Williams, G.M. 1993. Alteration of rat liver endoplasmic reticulum Ca+2-ATPase thiol integrity by ciprofibrate, a peroxisome proliferator. Biochem. Pharmacol. 45:2093-2098
132. Orti, E., Bodwell, J.E., and Munck, A. 1992. Phosphorylation of steroid hormone receptors. Endocr. Rev. 13:105-128
133. Shalev, A., Siegrist-Kaiser, C.A., Yen, P.M., Wahli, W., Burger, A.G., Chin, W.W., and Meier, C.A. 1996. The peroxisome proliferator-activated receptor a is a phosphoprotein: regulation by insulin. Endocrinol. 137:4499-4502
134. Ahmad, S. 1995. Antioxidant mechanisms of enzymes and proteins. In Oxidative Stress and Antioxidant Defenses in Biology. S. Ahmad, editor. New York:Chapman & Hall. 238-272
135. Halliwell, B.H., and Gutteridge, J.M.C. 1989. Free Radicals in Biology and Medicine. Oxford, UK: Oxford University Press, pp
136. Gutteridge, J.M., and Halliwell, B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sei. 15:129-135
137. Sohal, R.S., Agarwal, S., Dubey, A., and Orr, W.C. 1993. Protein oxidative damage is associated with life expectancy of houseflies. Proc. Natl. Acad. Sei. USA. 90:7255-7259
138. Dizdaroglu, M. 1992. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275:331-342
139. Harman, D. 1956. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 11:298-300
140. Beckman, K.B., and Ames, B.N. 1998. The free radical theory of aging matures. Physiol. Rev. 78:547-581
141. Bunker, V.W. 1992. Free radicals, antioxidants and ageing. Med. Lab. Sei. 42:299-312
142. Shigenaga, M.K., Hagen, T.M., and Ames, B.N. 1994. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sei. USA. 91:10771-10778
143. Sohal, R.S. 1981. Age Pigments. Amsterdam: Elsevier, pp
144. Michara, M., Uchiyama, M., and Fukuzawa, K. 1980. Thiobarbituric acid value on fresh homogenate of rat as a parameter of lipid peroxidation in aging, CC14 intoxication, and vitamin E deficiency. Biochem. Med. 23:302-311
145. Hajihara, M., Nishigaki, I., Maseki, M., and Yaggi, K. 1984. Age dependent changes in lipids peroxide levels in the lipoprotein fractions of human serum. J. Gerontol. 39:269-272
146. Spencer, N.F.L., Poynter, M.E., Im, S.-Y., and Daynes, R.A. 1997. Constitutive activation of NF-κ in an animal model of aging. Int. Immunol. 9:1581-1588
147. Fraga, C.G., Shigenaga, M.K., Park, J.W., Degan, P., and Ames, B.N. 1990. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ and urine. Proc. Natl. Acad. Sei. USA. 87: 4533-4537
148. Park, J.W., and Ames, B.N. 1988. 7-methylguanine adducts in DNA are normally present at high levels and increase on aging: analysis by HPLC with electrochemical detection. Proc. Natl. Acad. Sei. USA. 85: 7467-7470
149. Sack, M.N., Rader, T.A., Park, S., Bastin, J., McCune, S.A., and Kelly, D.P. 1996. Fatty acid oxidation enzyme gene expression is downregulated in failing heart. Circulation. 94:2837-2842
150. Sohal, R.S., Sohal, B.H., and Orr, W.C. 1995. Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Rad. Biol, & Med. 19:499-504
151. Schreck, R., Rieber, P., and Baeuerle, P.A. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2248
152. Schreck, R., Meier, B., Maennel, D.N., Droege, W., and Baeuerle, P.A. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J. Exp. Med. 175:1181-1194
153. Schreck, R., and Baeuerle, P.A. 1994. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κ. Methods Enzymol. 234:151-163
154. Schulze-Osthoff, K., Bauer, M., Vogt, M., Wesselborg, S., and Baeuerle, P.A. 1997. Reactive oxygen species as primary signals and second messengers in the activation of transcription factors. In Oxidative Stress and Signal Transduction. H. J. Forman, and E. Cadenas, editors. New York:Chapman & Hall. 239-259
155. Sen, C.K., and Packer, L. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10: 709-720
156. Baeuerle, P.A., and Henkel, T. 1994. Function and activation of NF-κB in the immune system. Ann. Rev. Immunol. 12:141-179
157. Helenius, M., Hanninen, M., Lehtinen, S.K., and Salminen, A. 1996. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κ. Biochem. J. 318:603-608
158. Helenius, H., Hanninen, M., Lehtinen, S.K., and Salminen, A. 1996. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardial muscle. J. Mol. Cell. Cardiol. 28:487-498
159. Korhonen, P., Helenius, M., and Salminen, A. 1997. Age-related changes in the regulation of transcription factor NF-κB in rat brain. Neurosci. Lett. 225:61-64
160. Supakar, P.C., Jung, M.H., Song, C.S., Chatterjee, B., and Roy, A.K. 1995. Nuclear factor kB functions as a negative regulator for the rat androgen receptor gene and NF-κB activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 270:837-842
161. Ma, T.Y., Hollander, D., Dadufalza, V., and Krugliak, P. 1992. Effect of aging and caloric restriction on intestinal permeability. Exp. Gerontol. 27:321-333
162. Daynes, R.A., Araneo, B.A., Ershler, W.B., Maloney, C., Li, G.-Z., and Ryu, S.-Y. 1993. Altered regulation of IL-6 production with normal aging: Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 150:5219-5230
163. Ershler, W.B., Sun, W.H., Binkley, N., Gravenstein, S., Volk, M.J., Kamoske, G., Klopp, R.G., Roecker, E.B., Daynes, R.A., and Weindruch, R. 1993. Interleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphogne Cytokine Res. 12:225-230
164. Ershler, W.B. 1993. Interleukin-6, a cytokine for gerontologists. J. Am. Geriatr. Soc. 46:176-181
165. Huberman, M., Sredni, B., Stem, L., Kott, E., and Shalit, F. 1995. IL-2 and IL-6 secretion in dementia: Correlation with type and severity of disease. J. Neurol. Sei. 130:161-164
166. Huell, M., Strauss, S., Volk, B., Berger, M., and Bauer, J. 1995. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol. 89: 544-551
167. Spencer, N.F.L., and Daynes, R.A. 1996. IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5 B cells: possible involvement in age-associated cytokine dysregulation. Int. Immunol. 9:745-754
168. Hirano, T. 1994. Interleukin-6. In The Cytokine Handbook, Second Edition. A. Thomson, editor. San Diego: Academic Press. 145-168
169. Ramsay, A.J., Husband, A.J., Ramshaw, I.A., Bao, S., Matthaei, K.I., Koehler, G., and Kopf, M. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science. 264:561-563
170. Hirano, T., and Kishimoto, T. 1989. Interleukin-6: Possible implications in human diseases. Ric. Clin. Lab. 19:1-10
171. Hirano, T., Matsuda, T., Turner, M., Miyaska, N., Buchan, G., Tang, B., Sato, K., Shimuzu, M., Maine, R., Feldman, M., et al. 1988. Excessive production of interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18:1797-1801
172. Curtis, G.E., McAtear, C.A., Formela, L., Waish, A., and Shenkin, A. 1995. The effect of nutritional status on cytokine and acute phase protein responses to elective surgery. Cytokine. 7:380-388
173. Purohit, A., Ghilchik, M.W., Duncan, L., Wang, D.Y., Singh, A., Walker, M.M., and Reed, M.J. 1995. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J. Clin. Endocrinol. Metab. 80:3052-3058
174. Biffl, W.L., Moore, E.E., Moore, F.A., Carl, V.S., Kim, F.J., and Franciose, R.J. 1994. Interleukin 6 potentiates priming with platelet activating factor.Arch. Surgery. 129:1131-1136
175. Burstein, S.A. 1994. Effects of interleukin 6 on megakaryocytes and on canine platelet function. Stem Cells. 12:386-393
176. Manoiagas, S.C. 1995. Role of cytokines in bone resorption. Bone. 17:635-675
177. Trinchieri, G., and Gerosa, F. 1996. Immunoregulation by interleukin-12. J. Leukocyte Biol. 59:505-511
178. Trinchieri, G., and Scott, P. 1994. The role of interleukin 12 in the immune response, disease and therapy
179. Ernst, D.N., Weigle, W.O., Noonan, D.J., McQuitty, D.N., and Hobbs, M.V. 1993. The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J. Immunol. 151:575-587
180. Poynter, M.E., Mu, H.H., Chen, X.P., and Daynes, R.A. 1997. Activation of NKl.l + Tcells in vitro and their possible role in age-associated changes in inducible IL-4 production. Cell. Immunol. 179:22-29
181. Papanicolaou, D.A., Wilder, R.L., Manoiagas, S.C., and Chrousos, G.P. 1998. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128:127-137
182. Poynter, M.E., and Daynes, R.A. in preparation. Age-associated alterations in iNOS regulation
183. Tracey, K.J. 1994. Tumor necrosis factor-alpha. In The Cytokine Handbook, Second Edition. A. Thomson, editor. San Diego:Academic Press. 289-304
184. Beg, A.A., Finco, T.S., Nantermet, P.V., and Baldwin, A.S. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13: 3301-3310
185. Stancovski, I., and Baltimore, D. 1997. NF-κ activation: the NOS kinase revealed? Cell. 91:299-302
186. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science. 278:818-819
187. Beier, K., Volkl, A., and Fahimi, D. 1997. TNF-α downregulates the peroxisome proliferator activated receptor-a and the mRNAs encoding peroxisomal proteins in rat liver. FEBS Letters. 412:385-387
188. Calandra, T., Bemhagen, J., Mitchell, R.A., and Bucala, R. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902
189. Calandra, T., Bemhagen, J., Metz, C.N., Spiegel, L.A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 377:68-71
190. Mitchell, R., Bacher, M., Bernhagen, J., Pushkarskaya, T., Seidin, M.F., and Bucala, R. 1995. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154:3863-3870
191. Chorinchath, B.B., Kong, L.Y., Mao, L., and McCallum, R.E. 1996. Age-associated differences in TNF-a and nitric oxide production in endotoxic mice. J. Immunol. 156:1525-1530
192. Ray, A., and Prefontaine, K.E. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sei. USA. 91:752-756
193. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., and Jr., A.S.B. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:283-286
194. Inoue, H., and Tanabe, T. 1998. Transcriptional role of the nuclear factor kB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Comm. 244:143-148
195. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. 1995. Transcriptional roles of nuclear factor κB and nuclear factor-inretleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 c e l l s. / Biol. Chem. 270:31315-31320
196. D'Acquisto, F., luvone, T., Rombola, L., Sautebin, L., Di Rosa, M., and Carnuccio, R. 1997. Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. F.E.B.S. Lett. 418:175-178
197. Crofford, L.J., Tan, B., McCarthy, C.J., and Hla, T. 1997. Involvement of nuclear factor KB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 40: 226-236
198. De Witt, D.L. 1991. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1083:121-134
199. Meydani, S.N., Meydani, M., Verdon, C.P., Shapiro, A.A., Blumberg, J.B., and Hayes, K.C. 1986. Vitamin B supplementation suppresses prostaglandin B synthesis and enhances the immune response of aged mice. Mech. Ageing Dev. 34:191-201
200. Meydani, S.N., Wu, D., Santos, M.S., and Hayek, M.G. 1995. Antioxidants and immune response in aged persons: overview of present evidence. Am. J. Clin. Nutr. 62(suppl): 1462S-1476S
201. Hayek, M.G., Mura, C., Wu, D., Beharka, A.A., Han, S.N., Paulson, K.E., Hwang, D., and Meydani, S.N. 1997. Enhanced expression of inducible cyclooxygenase with age in murine macrophages. J. Immunol. 159:2445-2451
202. Hayek, M.G., Meydani, S.M., Meydani, M., and Blumberg, J.B. 1994. Age differences in eicosanoid production of mouse splenocytes: effects on mitogen-induced T-cell proliferation. J. Gerontol. 49:B197-B207
203. Kulmacz, R.J., and Lands, W.E.M. 1997. Peroxide tone in eicosanoid signaling. In Oxidative Stress and Signal Transduction. H. J. Forman, and E. Cadenas, editors. New York:Chapman & Hall. 134-156
204. Spear, N., Estevez, A.G., Radi, R., and Beckman, J.S. 1997. Peroxynitrite and cell signaling. In Oxidative Stress and Signal Transduction. H.J. Forman, and E. Cadenas, editors. New York:Chapman & Hall. 32-51
205. Salvemini, D., Misko, T.P., Masferrer, J.L., Seibert, K., Currie, M.G., and Needleman, P. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sei. USA. 90:7240-7244
206. Daynes, R.A., and Araneo, B.A. 1992. Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging: Immunol. & Infect. Dis. 3:135-154
207. Araneo, B.A., Woods, M.L., and Daynes, R.A. 1993. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: Hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant Hepatitis B surface antigen. J. Infec. Dis. 167:830-840
208. Araneo, B.A., Dowell, T., Terui, T., Deigel, M., and Daynes, R.A. 1991. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine B cells. Blood. 78:688-699
209. Miller, R.A., Flurkey, K., and Patel, H. 1990. Signal transduction pathways in T lymphocytes from old mice. Aging: Immunol. & Infect. Dis. 2:97-103
210. Blitstein-Willinger, E., and Diamanstein, T. 1978. Inhibition by isoptin (a calcium antagonist) of mitogenic stimulation of lymphocytes prior to the S-phase. Immunol. 4:591-603
211. Fulop Jr., T., Leblanc, C., Lacombe, G., and Dupuis, G. 1995. Cellular disruption of protein kinase C isozymes in CD3-mediated stimulation of human T lymphocytes with aging. F.E.B.S. Lett. 375:69-74
212. Whisler, R.L., Newhouse, Y.G., Grants, I.S., and Hackshaw, K.V. 1995. Differential expression of the alphaand beta-isoforms of protein kinase C in peripheral blood T and B cells from young and elderly adults. Mech. Ageing Dev. 77:197-211
213. Shi, J., and Miller, R.A. 1992. Tyrosine-specific protein phosphorylation in response to anti-CD3 antibody is diminished in old mice. J. Gerontol. 47:B147-B153
214. Patel, H.R., and Miller, R.A. 1992. Age-associated changes in mitogen-induced protein phosphorylation in murine T lymphocytes. Eur. J. Immunol. 22:253-260
215. Schwab, R., Hausman, P.B., Rinnooy-Kan, E., and Weksler, M.E. 1985. Immunological studies of ageing. X. Impaired T lymphocytes and normal monocyte response from elderly humans to the mitogenic antibodies OKT3 and Leu 4. Immunol. 55:677-684
216. Hallgren, H.M., Bergh, N., Rodysill, K.J., and O'Leary, J. 1988. Lymphocyte proliferative response to PHA and anti-CD-3/Ti monoclonal antibodies, B cell surface marker expression, and serum IL-2 receptor levels as biomarkers of age and health. Mech. Ageing Dev. 43:175-185
217. Kay, M.M.B. 1979. B cell responsiveness in aging. Mech. Ageing Dev. 11:295-346
218. Hori, Y., Perkins, E.H., and Halsall, M.K. 1973. Decline in phytohemagglutinin responsiveness of spleen cells from aged mice. Proc. Soc. Exp. Biol. Med. 144:48-53
219. Hallgren, H.M., Buckley, C.E., Gilbertsen, V.A., and Yunis, E.J. 1973. Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J. Immunol. 111:1101-1107
220. Inkeles, B., Innes, J.B., Kuntz, M.M., Kadish, A.S., and Weksler, M.E. 1977. Immunological studies of aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins. J. Exp. Med. 145:1176-1187
221. Walters, C.S., and Claman, H.N. 1975. Age-related changes in cell-mediated immunity in Balb/c mice. J. Immunol. 115:1438-1443
222. Sano, T.K., Asano, Y., and Tada, T. 1990. Analysis of age-related degeneracy of T-cell repertoire: localized functional failure in CD8+ B cells. Scand. J. Immunol. 32:545-553
223. Patel, P.J. 1981. Aging and antimicrobial immunity. J. Exp. Med. 154:821-831
224. Doherty, P.C. 1977. Diminished B cell surveillance function in old mice infected with lymphocyte choriomeningitis virus. Immunol. 32:751-754
225. Mosmann, T.R., and Sad, S. 1996. The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol. Today. 17:138-146
226. Brown, M.A., and Hural, J. 1997. Functions of IL-4 and control of its expression. Crit Rev Immunol. 17: 1-32
227. Yoshimoto, T., and Paul, W.E. 1994. CD4P0S, NK1. 1P°S B cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-1295
228. Schwab, R., and Schmitt, K. 1983. Dysregulated production of cytokines by CD4+ B cell subsets from aging humans. J. Immunol. 150:33A
229. Kirman, I., Zhao, K., Tschepen, I., Szabo, P., Richter, G., Nguyen, H., and Weksler, M.E. 1996. Treatment of old mice with IL-2 corrects dysregulated IL-2and IL-4 production. Int. Immunol. 8:1009-1015
230. Daynes, R.A., and Araneo, B.A. 1992. Natural regulators of T-cell lymphokine production in vivo. Journal of Immunotherapy. 12:174-179
231. Wiedmeier, S.E., Mu, H.-H., Araneo, B.A., and Daynes, R.A. 1994. Age and microenvironment-associated influences by PDGF on T-cell function. J. Immunol. 152:3417-3426
232. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E., and Flavell, R.A. 1997. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ B cells. J. Exp. Med. 185:461-469
233. Thoman, M.L., and Weigle, W.O. 1989. The cellular and subcellular bases of immunosenescence. Adv. Immunol. 46:221-261
234. Schwab, R., and Weksler, M.E. 1989. B cell surface determinants and function in aging. Immunol. Ser. 45:317-331
235. Brohee, D., van Haeuerbeek, M., Kennes, B., and Neve, P. 1991. Changing patterns of CD5+ CD20+ double positive lymphocytes with ageing and cytotoxic chemotherapy. Mech. Ageing Dev. 58:127-138
236. Booker, J.K., and Haughton, G. 1992. Characterization of expanded populations of peritoneal CD5 B cells specific for phosphatidyl choline in old B10.H-2aH-4bp/Wts Mice. Anw. N.Y.Acad. Sei. 651:494-497
237. Gottesman, R.S., Edington, J., Tsiagbe, V.K., and Thorbecke, G.J. 1993. Influence of cytokines and the effect of aging on colony formation by B-cell subsets. Aging: Immunol. & infect. Dis. 4:197-211
238. O'Garra, A., Chang, R., Go, N., Hastings, R., Haughton, G., and Howard, M. 1992. Ly-1 B (B-l) cells are the main source of B cell derived interleukin 10. Eur. J. Immunol. 22:711-717
239. Stall, A.M., Adams, S., Herzenberg, L.A., and Kantor, A.B. 1992. Characteristics and development of the murine B-lb (Ly-1 B sister) cell population. Ann. N.Y.Acad. Sei. 651:33-43
240. Reap, E.A., Sobel, E.S., Cohen, P.L., and Eisenberg, R.A. 1992. The Role of CD5+ B cells in the production of autoantibodies in murine systemic lupus erythematosus. Ann. N. Y. Acad. Sei. 651:588-590
241. Plater-Zyberk, C., Brown, C.M.S., Andrew, E.M., and Maini, R.N. 1992. CD5+Bcells in rheumatoid arthritis. Ann. N. Y. Acad. Sei. 651:540-550
242. Xu, H.J., Roberts-Thomson, P.J., Ahern, M.J., and Aola, H. 1992. Comparative evaluation of CD5 B cells in patients with rheumatoid arthritis and essential mixed cryoimmunoglobulinemia using FACS analyzer and FACSCAN flow cytometer. Ann. N. Y. Acad. Sei. 651:594-598
243. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C., Binet, J.L., and CLL, T.F.C.G.O. 1991. Bcell chronic lymphocytic leukemia: present status and future directions. Blood. 78:1901-1914
244. Stein, R., Witz, I.P., Ovadia, J., Goldenberg, D.M., and Yron, I. 1991. CD5+ B cells and naturally occurring autoantibodies in cancer patients. Clin. Exp. Immunol. 85:418-423
245. Lyngbye, J., and Kroll, J. 1971. Quantitative Immunoelectrophoresis of proteins in serum from a normal population: season-, age-, and sex-related variations. Clin. Chem. 17:495-500
246. Goidl, E.A., Stashak, P.N., Martin-McEvoy, S.J., and Hiernaux, J.R. 1988. Age related changes in serum immunoglobulin isotypes and isotype subclass levels among standard long-lived and autoimmune and immunodeficient strains of mice. Aging: Immunol. & Infect. Dis. 1:227-236
247. Kato, K., and Hirokawa, K. 1993. Qualitative and quantitative analysis of autoantibody production in aging mice. Aging: Immunol. & Infect. Dis. 1:177-190
248. Spencer, N.F.L., Norton, S.D., Harrison, L.L., Li, G.Z., and Daynes, R.A. 1996. Dysregulation of IL-10production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp. Gerontol. 31:393-408
249. Miller, R.A. 1989. Minireview. The cell biology of aging: immunological models. J. Gerontol. 44:B4-B8
250. Miller, R.A. 1991. Aging and immune function. Int. Rev. Cytol. 124:187-214
251. Miller, R.A. 1996. The aging immune system: primer and prospectus. Science. 273:70-74
252. Simberkoff, M.S., Cross, A.P., Al-Ibrahim, M., Baltch, A.L., Geiseler, P.J., Nadler, J., Richmond, A.S., Smith, R.P., Schiffman, G., Shepard, D.S., et al. 1986. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration cooperative study. New Engl. J. Med. 17:1318-1327
253. Immunization Practices Advisory Committee. 1989. Pneumococcal polysaccharide vaccine. Morbit. Mortal. Weekly Rep. 38:64-76
254. Arden, N.H., Patriarca, P.A., and Kendal, A.P. 1986. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. In Options for the Control of Influenza. A. P. Kendal, and P. A. Patriarca, editors. New York: Alan R. Loss, Inc. 155-168
255. Feery, B.J., Evered, M.G., and Morrison, E.I. 1979. Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J. Infec. Dis. 139
256. Glezen, W.P. 1982. Serious morbidity and mortality associated with influenza epidemics. Epidemiol. Rev. 4:25-44
257. Immunization Practices Advisory Committee. 1985. Diptheria, tetanus and pertussis: guidelines for vaccine prophylaxis and other preventative measures. Morbit. Mortal. Weekly Rep. 34:405-414, 419-426
258. Immunization Practices Advisory Committee. 1990. Tetanus-United States, 1987 and 1988. Morbit. Mortal. Weekly Rep. 39:37-41
259. Bennett, R.G., Powers, D.C., Remsburg, R.E., Scheve, A., and Clements, M.L. 1996. Hepatitis B virus vaccination for older adults. J. Am. Geriatr. Soc. 44:699-703
260. Clements, M.L., Miskovesky, E., Davidson, M., Cupps, T., Kumwenda, N., Sandman, L.A., West, D., Hesley, T., Ioli, V., Miller, W., et al. 1994. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surbace antigen (S) or PreS2 + S antigens. J. Infec. Dis. 170:510-516
261. Steere, A.C., Sikand, V.K., Meurice, F., Parenti, D.L., Fikrig, E., Schoen, R.T., Nowakowski, J., Schmid, C.H., Laukamp, S., Buscarino, C., et al. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipiprotein A with adjuvant. Lyme disease vaccine study group. New Engl. J. Med. 339:209-215
262. Sigal, L.H., Zahradnik, J.M., Lavin, P., Patella, S.J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., et al. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant outer-surface protein A Lyme disease vaccine study consortium. New Engl. J. Med. 339:216-222
263. Steigbigel, R.T., and Benach, J.L. 1998. Immunization against Lyme disease-an important first step. New Engl. J. Med. 339:236-264
264. Wormser, G.P., Nowakowski, J., Nadelman, R.B., Schwartz, I., McKenna, D., Holmgren, D., and Aguero-Rosenfeld, M. 1998. Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State. Infection. 26:208-212
265. Fulk, R.V., Fedson, D.S., Huber, M.A., Fitzpatrick, J.R., and Kasel, R.A. 1970. Antibody responses in serum and nasal secretions according to age of recipient and method of administration of A2/Hong Kong/68 inactivated influenzia virus vaccine. J. Immunol
266. Waldman, R.H., Bergmann, K., Stone, J., Howard, S., Chiodo, V., Jacknowitz, A., Waldman, E.R., and Khakoo, R. 1987. Age-dependent antibody response in mice and humans following oral influenza immunization. J. Clin. Immunol. 7:327-332
267. Taylor, L.D., Daniels, C.K., and Schmucker, D.L. 1990. Does aging impair gastrointestinal mucosal immunity? Aging: Immunol. & Infect. Dis. 2:205-209
268. Ganguly, R., Stablein, J., Lockey, R.F., Shamblin, P., and Vargas, L. 1986. Defective antimicrobial functions of oral secretions in the elderly. J. Infec. Dis. 153:163-164
269. Korsrud, F.R., and Brnadzaeg, P. 1980. Immune systems of human nasopharyngeal and palatine tonsils: histomorphometry of lymphoid components and quantification of immunoglobulin-producing cells in health and disease. Clin. Exp. Immunol. 39:361-370
270. World Health Organization. 1996. World Health Statistics, Annual, 1995. Section B: Causes of death, life tables and mortality trends., Geneva
271. Daynes, R.A., and Araneo, B.A. 1992. Programming of lymphocyte responses to activation: extrinsic factors, provided microenvironmentally, confer flexibility and compartmentalization to T-cell function. In Regulation and Functional Significance of T-Cell Subsets. R. L. Coffman, editor. Basel:Karger. 1-20
272. Loria, R.M., and Padgett, D.A. 1992. Androstenediol regulates resistance against lethal infections in mice. Arch. Virol. 127:103-115
273. Loria, R.M., Regelson, W., and Padgett, D.A. 1990. Immune response facilitation and resistance to virus and bacterial infections with dehydroepiandrosterone (DHEA). In The Biologic Role of Dehydroepiandrosterone( DHEA). M. Kalimi, and W. Regelson, editors. New York: Walter de Gruyter. 107-130
274. Loria, R.M., Padgett, D.A., and Huynh, P.N. 1996. Regulation of the immune response by dehydroepiandrosterone and its metabolites. J. Endocrinol. 150 Suppl:S209-S220
275. Rasmussen, K.R., Healey, M.C., Cheng, L., and Yang, S. 1995. Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum. J. Parasitol. 81:429-433
276. Rasmussen, K.R., Martin, E.G., Arrowood, M.J., and Healey, M.C. 1991. Effects of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Cryptosporidium parvum. J. Protozool. 38:157S-159S
277. Rasmussen, K.R., and Healey, M.C. 1992. Dehydroepiandrosterone-induced regulation of Cryptosporidium parvum infections in aged Syrian golden hamsters. J. Parasitol. 78:554-557
278. Rasmussen, K.R., Arrowood, M.J., and Healey, M.C. 1992. Effectiveness of dehydroepiandrosterone in reduction of cryptosporidial activity in immunosuppressed rats. Antimicrob. Agents Chemother. 36:220-222
279. Daynes, R.A., Dudley, D.J., and Araneo, B.A. 1990. Regulation of murine lymphokine production II. Dehydroepiandrosterone is natural enhancer of interleukin 2 synthesis by helper B cells. Eur. J. Immunol. 20:793-802
280. Suzuki, T., Suzuki, N., Daynes, R.A., and Engleman, E. 1991. Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human B cells. Clin. Immunol. Immunopathol. 61:202-211
281. Danenberg, H.D., Alpert, G., Lustig, S., and Ben-Nathan, D. 1992. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob. Agents Chemother. 36:2275-2279
282. Enioutina, E.Y., Poynter, M.E., Visic, D.M., and Daynes, R.A. submitted. Restoration of normal mucosal immune responses in aged mice following supplementation with antioxidants or with specific activators of the PPARa transcription factor. Int. Immunol
283. Hennebold, J.D., Poynter, M.E., and Daynes, R.A. 1995. DHEA and immune function: activities and mechanism of action. Semin. Reprod. Endocrinol. 13.257-269
284. Daynes, R.A., and Araneo, B.A. 1994. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Ann. N. Y. Acad. Sei. 730:144-161
285. Daynes, R.A., Enioutina, E.Y., Butler, S., Mu, H.H., McGee, Z.A., and Araneo, B.A. 1996. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect. Immun. 64:1100-1109
286. Danenberg, H.D., Ben-Yehuda, A., Zakay-Rones, Z., and Friedman, G. 1995. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine. 13:1445-1448
287. Evans, T.G., Judd, M.E., Dowell, T., Poe, S., Daynes, R.A., and Araneo, B.A. 1996. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine. 14:1531-1537
288. Araneo, B., Dowell, T., Woods, M.L., Daynes, R.A., Judd, M., and Evans, T. 1995. DHEAS as an effective vaccine adjuvant in elderly humans. In Annals of the New York Academy of Sciences: Dehydroepiandrosterone (DHEA) and Aging. F. L. Bellino, R. A. Daynes, R J. Homsby, D. H. Lavrin, and J. E. Nestler, editors. New York:The New York Academy of Sciences. 232-248
289. Degelau, J., Guay, D., and Hallgren, H. 1997. The effect of DHEAS on influenza vaccination in aging adults. J. Am. Geriatr. Soc. 45:747-751
290. Ben-Yehuda, A., Danenberg, H.D., Zakay-Rones, Z., Gross, D.J., and Friedman, G. 1998. The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech. Ageing Dev. 102:299-306
291. Danenberg, H.D., Ben-Yehuda, A., Zakay-Rones, Z., Gross, D.J., and Friedman, G. 1997. Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J. Clin. Endocrinol. Metab. 82:2911-2914
292. Spencer, N.F.L., Poynter, M.E., Hennebold, J.D., Mu, H.-H., and Daynes, R.A. 1995. Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisome activities? Ann. N. Y. Acad. Sei. 774:200-216
293. Meydani, S.N., Meydani, M., Blumberg, J.B., Leka, L.S., Siber, G., Loszewski, R., Thompson, C., Pedrosa, M.C., Diamond, R.D., and Stollar, B.D. 1997. Vitamin E supplementation and immune response in healthy elderly subjects. A randomized controlled trial. J.A.M.A. 277:1380-1386
294. Araneo, B.A., Shelby, J., Li, G.-Z., Ku, W., and Daynes, R.A. 1993. Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch. Surgery. 128:318-325
295. Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I.P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARa but not by PPARy activators. Nature. 393:790-793
296. Beg, A.A., and Baltimore, D. 1996. An essential role for NF-κB in preventing TNF-a-induced cell death. Science. 274:782-784
297. Antwerp, D.J., Seamus, J.M., Kafri, T., Green, D.R., and Verma, I.M. 1996. Suppression of TNF-a-induced apoptosis by NF-κB. Science. 274:787-789
298. Wang, C.-Y., Mayo, M.W., and Baldwin, S.S. 1996. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:784-787
299. Callahan, J.E., Kappler, J.W., and Marrack, P. 1993. Unexpected expansions of CD8-bearing cells in old mice. J. Immunol. 151:6657-6669
300. Lerner, A., Yamada, T., and Miller, R.A. 1989. Pgp-lhi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur. J. Immunol. 19:977-982
301. Ernst, D.N., Hobbs, M.V., Torbett, B.E., Glasebrook, A.L., Rehse, M.A., Bottomly, K., Hayakawa, K., Hardy, R.R., and Weigle, W.O. 1990. Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ B cells from young and aged mice. J. Immunol. 145:1295-12302
302. Pilarski, L.M., Yacyshyn, B.R., Jensen, G.S., Pruski, E., and Pabst, H.F. 1991. βl integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression. J. Immunol. 147:830-837
303. Vazquez, M., Merlos, M., Adzet, T., and Laguna, J.C. 1996. Decreased susceptibility to copper-induced oxi dation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition. Br. J. Pharmacol. 117:1155-1162
304. Boccuzzi, G., Aragno, M., Seccia, M., Brignarardello, E., Tamagno, E., Albano, E., Danni, O., and Bellomo, G. 1997. Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat. Free Rad. Biol. & Med. 22:1289-1294
305. Hoffman, R., Brook, G.J., and Aviram, M. 1992. Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis. 93:105-113
306. Aragno, M., Tamagno, E., Boccuzzi, G., Brignardello, E., Chiarpotto, E., Pizzini, A., and Danni, O. 1993. Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. Biochem. Pharmacol. 46:1689-1694
307. Mohan, P.F., and Jacobson, M.S. 1993. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Am. J. Med. Sei. 306:10-15
308. Inoue, I., Noji, S., Awata, T., Takahashi, K., Nakajima, T., Sonoda, M., Komoda, T., and Katamaya, S. 1998. Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor alpha is associated with Cu+2, Zn+2-superoxide dismutase in the liver. Life Sei. 63:135-144
309. Soliman, M.S., Cunningham, M.L., Morrow, J.D., Roberts, L.J., and Badr, M.Z. 1997. Evidence against peroxisome proliferation-induced hepatic oxidative damage. Biochem. Pharmacol. 53:1369-1374
310. Inoue, I., Noji, S., Shen, M., Takahashi, K., and Katayama, S. 1997. The peroxisome proliferator-activated receptor a (PPARa) regulates the plasma thiobarbituric acid-reactive substance (TBARS) level. Biochem. Biophys. Res. Comm. 237:606-610
311. Fleming, J.E., Reveillaud, I., and Niedzwiecki, A. 1992. Role of oxidative stress in Drosophila aging. Mutat. Res. 275:267-279
312. Orr, W.C., and Sohal, R.S. 1994. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263:1128-1130
313. McKay, L.I., and Cidlowski, J.A. 1998. Cross-talk between nuclear factor-kB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrin. 12:45-56
314. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:79-82
315. Jiang, C., Ting, A.T., and Seed, B. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:82-86
316. Packer, L., Roy, S., and Sen, C.K. 1997. α-Lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv. Pharmacol. 38:79-101
317. Miyata, K.S., McCaw, S.E., Patel, H.V., Rachubinski, R.A., and Capone, J.P. 1996. The orphan nuclear hormone receptor LXRa interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271:9189-9192
318. Na, S.-Y., Lee, S.-K., Han, S.-J., Choi, H.-S., Im, S.-Y., and Lee, J.W. 1998. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor-kB-mediated transactivations. J. Biol. Chem. 273:10831-10834
319. Beier, K., Volkl, M., and Fahimi, H.D. 1993. The impact of aging on enzyme proteins of rat liver peroxisomes: quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Arch. T Cell Pathol. 63:139-146
320. Nadiv, O., Shinitzky, M., Manu, H., Hecht, D., Roberts Jr, C.T., LeRoith, D., and Zick, Y. 1994. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem. J. 298:443-450
321. Gareau, R., Goulet, H., Chenard, C., Caron, C., and Brisson, G.R. 1991. Fluorescence studies on aged and young erythrocyte populations. Cell. Mol. Biol. 37:15-19
322. Laganiere, S., and Femandes, G. 1991. Study on the lipid composition of aging Fischer-344 rat lymphoid cells: effect of long-term calorie restriction. Lipids. 26:472-478
323. Shinitzky, M. 1987. Patterns of lipid changes in membranes of the aged brain. Gerontology. 33:149-154
324. Hegner, D. 1980. Age-dependence of molecular and functional changes in biological membrane properties. Mech. Ageing Dev. 14:101-118
325. Kamataki, T., Maeda, K., Shimada, M., Kitani, K., Nagai, T., and Kato, R. 1985. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats. J. Pharmacol. Exp. Ther. 233:222-228
326. Yamoto, T., Ohashi, Y., Teranishi, M., Takaoka, M., Manabe, S., Matsunuma, N., and Makita, T. 1995. Agerelated changes in the susceptibility to clofibric acid, a hypolipidemic agent, of male rat liver. Toxicol. Lett. 78:141-145
327. Perichon, R., and Bourre, J.M. 1996. Aging-related decrease in liver peroxisomal fatty acid oxidation in control and clofibrate-treated mice. A biochemical study and mechanistic approach. Mech. Ageing Dev. 87:115-126
328. Perichon, R., and Bourre, J.M. 1995. Liver peroxisomal fatty acid oxidizing system during aging in control and Clofibrate treated mice. Biochem. and Mol. Biol. International. 37:475-480
329. Chandoga, J., Balaz, V., and Balazova, H. 1984. Changes in the activities of peroxisomal, lysosomal, and mitochondrial enzymes of the rat in aging. Bratisl. Lek. Listy. 81:176-181
330. Haining, J.L., and Legan, J.S. 1973. Catalase turnover in rat liver and kidney as a function of age. Exp. Gerontol. 8:85-91
331. Matsuo, M., Gomi, F., and Dooley, M.M. 1992. Age-related alterations in antioxidant capacity and lipid peroxidation in brain, liver, and lung homogenates of normal and vitamin E-deficient rats. Mech. Ageing Dev. 64:273-292
332. Pieri, C., Zs.-Nagy, I., Mazzufferi, G., and Giuli, C. 1975. The aging of rat liver as revealed by electron microscopic morphometry. Exp. Gerontol. 10:291-304
333. Rao, G., Xia, E., and Richardson, A. 1990. Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats. Mech. Ageing Dev. 53:49-60
334. Semsei, I., Rao, G., and Richardson, A. 1989. Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restriction. Biochem. Biophys. Res. Comm. 164:620-625
335. Horbach, G.J., van Asten, J., G., and van Bezooijen, C.F.A. 1990. The influence of ageing on the induction of the mRNAs of rat liver cytochrome P450IIB1 and P450IIB2. Biochem. Pharmacol. 40:529-533
336. Masters, C.J., and Crane, D.I. 1995. On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech. Ageing Dev. 80:69-83
337. Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., and Wahli, W. 1994. Regulation of the peroxisome proliferator-activated receptor a gene by glucocorticoids. J. Biol. Chem. 269:24527-24530
338. Lemberger, T., Saladin, R., Vasquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., and Auwerx, J. 1996. Expression of the peroxisome proliferator-activated receptor a gene is stimulated by stress and follows a diumal rhythm. J. Biol. Chem. 19:1764-1769
339. Steineger, H.H., Sorensen, H.N., Tugwood, J.D., Skrede, S., Spydevold, O., and Gautvik, K.M. 1994. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells: Hormonal modulation of fatty-acidinduced transcription. Eur. J. Biochem. 225:967-974
340. Inoue, I., Shino, K., Noji, S., Awata, T., and Katayama, S. 1998. Expression of peroxisome proliferator-activated receptor a (PPARa) in primary cultures of human vascular endothelial cells. Biochem. Biophys. Res. Comm. 246:370-374
341. Sterchele, P.F., Sun, H., Peterson, R.E., and Vanden Heuvel, J.P. 1996. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Arch. Biochem. Biophys. 326:281-289
342. Hertz, R., and Bar-Tana, J. 1987. Increased response to peroxisomal proliferators in starved rats. Biochim. Biophys. Acta. 917:57-61
343. Weindruch, R., and Sohal, R.S. 1997. Seminars in medicine of the Beath Israel Deaconess Medical Center. Caloric intake and aging. New Engl. J. Med. 337:986-994
344. Hyde, S.R., and McCallum, R.E. 1992. Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect. Immun. 60:976-982
345. Tateda, K., Matsumoto, T., Miyazaki, S., and Yamaguchi, K. 1996. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect. Immun. 64:769-774
346. Gearing, K.L., Crickmore, A., and Gustafsson, J.-A. 1994. Structure of the mouse peroxisome proliferator activated receptor a gene. Biochem. Biophys. Res. Comm. 199:255-263
347. Ammendola, R., Mesuraca, M., Russo, T., and Cimino, F. 1994. The DNA-binding efficiency of Spl is affected by redox changes. Eur. J. Biochem. 225:483-489
348. Esposito, F., Cuccovillo, F., Morra, F., Russo, T., and Cimino, F. 1995. DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim. Biophys. Acta. 1260:308-314
349. Ammendola, R., Mesuraca, M., Russo, T., and Cimino, F. 1992. Spl DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues./ Biol. Chem. 267:17944-17948
350. Parmentier, J.H., Schohn, H., Bronner, M., Ferrari, L., Batt, A.M., Dauca, M., and Kremers, P. 1997. Regulation of CYP4A1 and peroxisome proliferator-activated receptor alpha expression by interleukin-1 β, interleukin-6, and dexamethasone in cultured fetal rat hepatocytes. Biochem. Pharmacol. 54:889-898
351. Reichlin, S. 1993. Neuroendocrine-immune interactions. New Engl. J. Med. 329:1246-1253
352. Knudsen, P.J., Dinarello, C.A., and Strom, T.B. 1987. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin-1 in U937 cells. J. Immunol. 139:4129-4134
353. Black, P.H. 1994. Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrob. Agents Chemother. 38:7-12
354. Beutler, B., Krochin, N., Milsark, I.W., Luedke, C., and Cerami, A. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science. 232:977-980
355. Fan, C.-Y., Pan, J., Chu, R., Lee, D., Kluckman, K.D., Usuda, N., Singh, I., Yeldandi, A.V., Rao, M.S., Maeda, N., et al. 1996. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271:24698-24710
356. Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A.V., Rao, M.S., and Reddy, J.K. 1998. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. J. Biol. Chem. 273:15639-15645
357. Muller, J.M., Rupee, R.A., and Baeuerle, P.A. 1997. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods. 11:301-312
358. Gebel, T., Arand, M., and Oesch, F. 1992. Induction of the peroxisome proliferator-activated receptor by fenofibrate in rat liver. F.E.B.S. Lett. 309:37-40
359. Furstenberger, G., Hagedorn, H., Jacobi, T., Besemfelder, E., Stephan, M., Lehmann, W.D., and Marks, F. 1991. Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-0-tetradecanoylphorbol-13-acetate in the mouse skin in vivo. J. Biol. Chem. 266:15738-15745
360. Hughes, M.A., and Brash, A.R. 1991. Investigation of the mechanism of biosynthesis of 8-hydroxyeicosatetraenoic acid in mouse skin. Biochim. Biophys. Acta. 1081:347-354
361. Jisaka, M., Kim, R.B., Boeglin, W.E., Nanney, L.B., and Brash, A.R. 1997. Molecular cloning and functional expression of a phorbol ester-inducible 8S-lipoxygenase from mouse skin. J. Biol. Chem. 272: 24410-24416
362. Krieg, P., Kinzig, A., Heidt, M., Marks, F., and Furstenberger, G. 1998. cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin. Biochim. Biophys. Acta. 1391:7-12
363. Silverman, E.S., Du, J., De Sanctis, G.T., Radmark, 0., Samuelsson, B., Drazen, J.M., and Collins, T. 1998. Egr-1 and Spl interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants. Am. J. Cell. Mol. Biol. 19:316-323
364. Zhou, Y.-C., and Waxman, D.J. 1998. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ. Health Perspect. 106, Supplement 4:983-988
365. Keller-Wood, M.E., and Dallman, M.F. 1984. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5:1-24
366. Fräser, R. 1992. Biosynthesis of adrenocortical steroids. In The Adrenal Gland, Second Edition. V. H. T. James, editor. New York:Raven Press Ltd. 117-130
367. Meikle, W.A., Daynes, R.A., and Araneo, B.A. 1991. Adrenal androgen secretion and biologic effects. In Endocrinology and Metabolism Clinics of North America. New aspects of adrenal cortical disease. D. H. Nelson, editor. Philadephia:W.B. Saunders Co. 381-400
368. Orentreich, N., Brind, J.L., Rizer, R.L., and Vogelman, J.H. 1984. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:551-555
369. Straub, R.H., Konecna, L., Hrach, S., Rothe, G., Kreutz, M., Scholmerich, J., Falk, W., and Lang, B. 1998. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83:2012-2017
370. Cascio, C., Prasad, V.V.K., Lin, Y.Y., Liberman, S., and Papadopoulos, V. 1998. Detection of P450cl7-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sei. USA. 95:2862-2867
371. Foulkes, R., Shaw, S., and Suitters, A. 1997. Immunological consequences of inhibiting dehydroepiandrosterone (DHEA) sulfatase in vivo. In Steroid Hormones and the T-Cell Cytokine profile. G. A. W. Rook, and S. Lightman, editors. Springer. 135-152
372. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S., and Dubois, R.N. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1183-1188
373. Saltiel, A.R., and Olefsky, J.M. 1996. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 45:1661-1669
374. Cerami, A. 1985. Hypoyhesis. Glucose as a mediator of aging. J. Am. Geriatr. Soc. 33:626-634
375. Monnier, V.M., Glomb, M., Elgawish, A., and Sell, D.R. 1996. The mechanism of collagen cross-linking in diabetes: a puzzle nearing resolution. Diabetes. 45 Suppl:S67-S72
376. Schmidt, A.M., Hon, O., Brett, J., Yan, S.D., Wautier, J.L., and Stern, D. 1994. Cellular receptors for glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arteroscler. Thromb. 14:1521-1528
377. Schmidt, A.M., Hori, O., Cao, R., Yan, S.D., Brett, J., Wautier, J.L., Ogawa, S., Kuwabara, K., Matsumoto, M., and Stern, D. 1996. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 45 Suppl:S77-S80
378. Schmidt, A.M., Hori, O., Chen, J.X., Li, J.F., Crandall, J., Zhang, J., Cao, R., Yan, S.D., Brett, J., and Stern, D. 1995. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96:1395-1403
379. Schmidt, A.M., Yan, S.D., Brett, J., Mora, R., Nowygrod, R., and Stern, D. 1993. Regulation of human mononuclear phagocyte migration and cell surface-binding proteins for advanced glycation end products. J. Clin. Invest. 91:2155-2168
380. Tontonoz, P., Nagy, L., Alvarez, J.G.A., Thomazy, V.A., and Evans, R.M. 1998. PPARa promotes monocyte/ macrophage differentiation and uptake of oxidized LDL. Cell. 93:241-252
381. Nagy, L., Tontonoz, P., Alvarez, J.G.A., Chen, H., and Evans, R.M. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARy. Cell. 93:229-240
382. Elstner, E., Muller, C., Koshizuka, K., Williamson, E.A., Park, D., Asou, H., Shintaku, P., Said, J.W., Heber, D., and Koeffler, H.P. 1998. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sei. USA. 95:8806-8811
383. Stout, R.W. 1987. Aging and atherosclerosis. Age Aging. 16:65-72
384. Duncan, A.K., Vittone, J., Fleming, K.C., and Smith, H.C. 1996. Cardiovascular disease in elderly patients. Mayo Clin. Proc. 71:184-196
385. Keller, N.M., and Feit, F. 1996. Coronary artery disease in the geriatric population. Prog. Cardiovasc. Dis. 38:407-418
386. Wenger, N.K. 1990. Cardiovascular disease. In Geriatric Medicine. C.K. Cassel, D.E. Riesenberg, L.B. Sorensen, and J. R. Walsh, editors. New York:Springer-Verlag. 152-163
387. Uchino, B.N., Cacioppo, J.T., Malarkey, W., Glaser, R., and Kiecolt-Glaser, J.K. 1995. Appraisal support predicts age-related differences in cardiovascular function in women. Health Psychol. 14:556-562
388. Unverferth, D.V., Fetter, J.K., and Unverferth, J.B. 1983. Human myocardial histologic characteristics in congestive heart failure. Circulation. 68:1194-1200
389. Henry, P.D., and Pacifico, A. 1998. Altering molecular mechanisms to prevent sudden arrhythmic death. Lancet. 351:1276-1278
390. Bishop, S.P., and Altschuld, R.A. 1970. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am. 7. Physiol. 218:153-159
391. Taegtmeyer, H., and Overturf, M.L. 1988. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 11:416-426
392. Moalic, J.M., Charlemagne, D., Mansier, P., Chevalier, B., and Swynghedauw, B. 1993. Cardiac hypertrophy and failure-a disease of adaption. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity. Circulation. 87:IV21-IV26
393. Swynghedauw, B., Besse, S., Assayag, P., Carre, F., Chevalier, B., Charlemagne, D., Delcayre, C., Hardouin, S., Heymes, C., and Moalic, J.M. 1995. Molecular and cellular biology of the senescent hypertrophied and failing heart. Am. J. Cardiol. 76:2D-7D
394. Takeyama, D., Kagaya, Y., Yamane, Y., Shiba, N., Chida, M., Takahashi, T., Ido, T., Ishide, N., and Takishima, T. 1995. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc. Res. 29:763-767
395. Massie, B.M., Schaefer, S., Garcia, J., McKiman, M.D., Schwartz, G.G., Wisneski, J.A., Weiner, M.W., and White, F.C. 1995. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 91:1814-1823
396. Christe, M.E., and Rodgers, R.L. 1994. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J. Mol. Cell. Cardiol. 26:1371-1375
397. Sack, M.N., Disch, D.L., Rockman, H.A., and Kelly, D.P. 1997. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. γ roc. Natl. Acad. Sei. USA. 94:6438-6443
398. Disch, D.L., Rader, T.A., Cresci, S., Leone, T.C., Barger, P.M., Vega, R., Wood, P.A., and Kelly, D.P. 1996. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression. Mol. Cell. Biol. 16: 4043-4051
399. Gonzalez, F.J., Fernandez-Salguero, P., Lee, S.S.T., Pineau, T., and Ward, J.M. 1995. Xenobiotic receptor knockout mice. Toxicol. Lett. 82/83:117-121
400. Morin, C.L., Pagliassotti, M.J., Windmiller, D., and Eckel, R.H. 1997. Adipose tissue-derived tumor necrosis factor-alpha activity is elevated in older rats. J Gerontol A Biol Sei Med Sei. 52:B 190-B195
401. Mohan, P.F., and Cleary, M.P. 1991. Short-term effects of dehydroepiandrosterone treatment in rats with diet-induced obesity. J. Nutr. 120:1103-1114
402. Schwartz, A.G. 1979. Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long term treatment with DHEA. Cancer Res. 39:1129-1132
403. Yen, T.T., Allan, J.A., and Pearson, D.V. 1977. Prevention of obesity in Avy/a mice by DHEA. Lipids. 12:409-413
404. Kurziman, I.D., Macewen, E.G., and Haffa, A.L.M. 1990. Reduction in body weight and cholesterol in spontaneously obese dogs by dehydroepiandrosterone. Intl. J. Obes. 14:95-104
405. MacEwen, E.G., and Kurzman, I.D. 1991. Obesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA). J. Nutr. 121 :S51-S55
406. Nestler, J.E., Barlascini, C.O., Clore, J.N., and Blackard, W.J. 1988. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in older men. J. Clin. Endocrinol. Metab
407. Cleary, M.P, and Zisk, J.F. 1986. Anti-obesity effect of two different levels of dehydroepiandrosterone in lean and middle-aged Zucker rats. Intl. J. Obes. 10:193-204
408. Zhou, Y.-T., Shimabukuro, M., Wang, M.-Y., Lee, Y., Higa, M., Milburn, J.L., Newgard, C.B., and Unger, R.H. 1998. Role of peroxisome proliferator-activated receptor a in disease of pancreatic β cells. Proc. Natl. Acad. Sei. USA. 95:8898-8903
409. Breitner, J.C. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med. 47:401-411
410. Breitner, J.C. 1996. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging. 17:789-794
411. McGeer, PL., Schulzer, M., and McGeer, E.G. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:425-432
412. Milewich, L., Garcia, R.L., and Gerrity, L.W. 1984. Steroid sulfatase and 17β-hydroxysteroid oxidoreductase activities in mouse tissues. J. Steroid Biochem. 21:529-538
413. Daynes, R.A., Araneo, B.A., Dowell, T.A., Huang, K., and Dudley, D. 1990. Regulation of murine lymphokine production in vivo III. The lymphoid tissue microenvironment exerts regulatory over T cell function. J. Exp. Med. 171:979-996
414. Hennebold, J.D., and Daynes, R.D. 1994. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinol. 135:67-75
415. Falany, C.N., Vazquez, M.E., and Kalb, J.M. 1989. Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem. J. 260:641-646